Improving drug development for children
BPCA INNOVATIVE TRIAL DESIGNS AND ASSAY DEVELOPMENTS IN PEDIATRIC THERAPEUTICS
This study is working to improve how new medicines are developed for kids by using new ideas and technology to make the process easier and more tailored to their needs, so that young patients can benefit from better treatments.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Duke University NIH-funded |
| Lab location | 1 site (Durham, United States) |
| Project ID | NIH-10936040 on NIH RePORTER |
What this research studies
This research focuses on enhancing the development of medications specifically for pediatric patients by addressing existing gaps in knowledge and methodologies. It aims to implement innovative trial designs and personalized therapeutic approaches that consider the unique developmental needs of children. The project will leverage new technologies, such as artificial intelligence and electronic health records, to streamline research processes and reduce the burden on young participants. By collaborating with various stakeholders, including the FDA and NIH, the research seeks to create a more effective framework for pediatric drug development.
Who could benefit from this research
Good fit: Ideal candidates for this research include pediatric patients who require medication for various health conditions.
Not a fit: Patients who are not children or adolescents may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to safer and more effective medications tailored specifically for children.
How similar studies have performed: Previous research has shown success in improving pediatric drug development through collaborative efforts and innovative methodologies.
Where this research is happening
Durham, United States
- Duke University — Durham, United States (Active)
Researchers
- Principal investigator: Benjamin, Daniel K. — Duke University
- Study coordinator: Benjamin, Daniel K.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.